Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt

Sponsor

Assiut University (Other)

Overall Status

Unknown status

CT.gov ID

NCT04339322

Collaborator

(none)

200

Enrollment

Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

The World Health Organization (WHO) has recently declared coronavirus disease 2019 (Covid-19) a public health emergency of international concern. Egypt is one of the countries that has been infected by Covid-19. The characteristics of clinical presentation, laboratory and radiological data are not yet studied. Outcomes of covid-19 in Egypt also have not been described yet.

Condition or Disease	Intervention/Treatment	Phase
Characteristics Diseases Outcome, Fatal	Other: Follow up

Detailed Description

Patients admitted to Assiut University hospital, Al Rajhi liver hospital and other covid-19 Quarantine hospitals will be included. The characteristics of patients will be described such as demographic data; age, sex,history of contact to COVID-19 patients or traveling abroad and their clinical manifestation such as fever,cough,shortness of breath, sore throat, diarrhea. Laboratory data will also be included such as blood picture,D-Dimer, serum ferritin, creatinine, liver enzymes, oxygen saturation and covid-19 polymerase chain reaction (PCR). Radiological data will be described as regarding chest X-ray and/or computed tomography.

Patients will be followed until complications, improvement, transfer to another hospital or death and their outcome will be described.

Study Design

Study Type:

Observational

Anticipated Enrollment :

200 participants

Observational Model:

Cohort

Time Perspective:

Prospective

Official Title:

Characteristics and Outcome of COVID-19 Among Egyptian Patients

Anticipated Study Start Date :

May 1, 2020

Anticipated Primary Completion Date :

Jul 30, 2020

Anticipated Study Completion Date :

Jul 30, 2020

Arms and Interventions

Arm	Intervention/Treatment
Patients with Covid-19 Patients with clinical presentation and confirmed as Covid-19 according to the definition of Egyptian Ministry of Health	Other: Follow up Follow up to assess the outcome until complications, improvement, death or being transferred to another quarantine hospital.

Arm

Intervention/Treatment

Patients with Covid-19

Patients with clinical presentation and confirmed as Covid-19 according to the definition of Egyptian Ministry of Health

Other: Follow up

Follow up to assess the outcome until complications, improvement, death or being transferred to another quarantine hospital.

Outcome Measures

Primary Outcome Measures

Demographics of Coronavirus Disease 2019 (COVID-19) in the cohort group [2 months]
Sheet recording age, sex, co-morbidity,history of contact
Clinical manifestations of Coronavirus Disease 2019 (COVID-19) [2 month]
Sheet recording symptoms and signs
Laboratory data of included Coronavirus Disease 2019 (COVID-19) cohort [2 months]
blood picture,D-Dimer, creatinine, liver enzymes
Radiological features of Coronavirus Disease 2019 (COVID-19) cohort [2 month]
Chest x-ray and/or Computed tomography

Secondary Outcome Measures

outcomes of Coronavirus Disease 2019 (COVID-19) infection in the cohort group [1 week]
Data recording of the outcomes of treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Inclusion Criteria:

Patients with diagnosis of Covid-19 .

Exclusion Criteria:

Patients refuse to participate in the study

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Assiut University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Haidi Karam, Lecturer of Tropical Medicine and Gastroenterology, Assiut University

ClinicalTrials.gov Identifier:

NCT04339322

Other Study ID Numbers:

COVID-19 in Egypt

First Posted:

Apr 9, 2020

Last Update Posted:

Apr 9, 2020

Last Verified:

Apr 1, 2020

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Haidi Karam, Lecturer of Tropical Medicine and Gastroenterology, Assiut University

Additional relevant MeSH terms:

COVID-19

Study Results

No Results Posted as of Apr 9, 2020